4.7 Article

Protracted course progressive supranuclear palsy

Journal

EUROPEAN JOURNAL OF NEUROLOGY
Volume 29, Issue 8, Pages 2220-2231

Publisher

WILEY
DOI: 10.1111/ene.15346

Keywords

microglia; pallidonigroluysian atrophy; Parkinsonian disorders; prognosis; progressive supranuclear palsy; Richardson syndrome; tau protein

Funding

  1. Rossy Foundation
  2. St. Louis American Parkinson Disease Association
  3. Michael J. Fox Foundation for Parkinson's Research
  4. Parkinson Canada Grant [PPG-2020-0000000025]
  5. NIH Clinical Center [NS075321, NS103957, NS107281, NS107281-03S1, NS0928, NS097437, U24 NS107198, U10NS077384, U54NS116025, U19 NS110456, AG64937, NS097799, NS075527, ES029524, NS109487, R61 AT010753, RO1NS118146, R01AG065214]
  6. Edmond J. Safra Philanthropic Foundation
  7. Foundation for Barnes--Jewish Hospital

Ask authors/readers for more resources

This study reveals a broader range of disease courses in progressive supranuclear palsy (PSP) than previously known. Time to gait dependence and cognitive impairment are proposed as prognostic milestones. Genetic polymorphisms in TRIM11 and SLC2A13 genes are associated with longer disease duration. The study suggests a subtype of PSP with protracted course and explores its relationship with protein misfolding, seeding activity, and propagation.
Background and purpose Progressive supranuclear palsy (PSP) encompasses a broader range of disease courses than previously appreciated. The most frequent clinical presentations of PSP are Richardson syndrome (RS) and PSP with a predominant Parkinsonism phenotype (PSP-P). Time to reach gait dependence and cognitive impairment have been proposed as prognostic disease milestones. Genetic polymorphisms in TRIM11 and SLC2A13 genes have been associated with longer disease duration (DD). Methods Methods used include retrospective chart review, genetic single nucleotide polymorphism analyses (in three cases), and neuropathology. Results We identified four cases with long (>10-15 years) or very long (>15 years) DD. Stage 1 PSP tau pathology was present in two cases (one PSP-P and one undifferentiated phenotype), whereas pallidonigroluysian atrophy (PSP-RS) and Stage 4/6 (PSP-P) PSP pathology were found in the other two cases. Three cases were homozygous for the rs564309-C allele of the TRIM11 gene and the H1 MAPT haplotype. Two were heterozygous for rs2242367 (G/A) in SLC2A13, whereas the third was homozygous for the G-allele. Conclusions We propose a protracted course subtype of PSP (PC-PSP) based on clinical or neuropathological criteria in two cases with anatomically restricted PSP pathology, and very long DD and slower clinical progression in the other two cases. The presence of the rs564309-C allele may influence the protracted disease course. Crystallizing the concept of PC-PSP is important to further understand the pathobiology of tauopathies in line with current hypotheses of protein misfolding, seeding activity, and propagation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available